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The period of adolescence is associated with complex 
psychological, physical and cognitive changes as 
children transition to adulthood. In more recent 
times this transition has taken on added complexities, 
particularly in developing countries undergoing 
by adolescents, HIV-infected children often have to face for the first 
time that they have AIDS and need to be on lifelong ARV treatment. 
The articles by Naidoo et al.[3] and Dawood[4] underscore some of 
the challenges in treating adolescent AIDS patients and issues that 
need to be considered, such as drug choices, treatment adherence, 
disclosure of HIV status, fear of stigma and discrimination and 
its implications with regard to secondary sexual development, 
and risks associated with horizontal transmission of HIV. Waning 
immunity from childhood immunisation and the development 
of new vaccines requiring delivery during adolescence introduce 
new challenges relating to vaccine 
delivery beyond childhood. The 
article by Tathiah et al.[5] shares 
experiences in the introduction of 
the human papillomavirus vaccine, 
which provides a strong foundation 
for the introduction of vaccines that 
target adolescents but are still being 
developed.
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Adolescent health
social and political changes, in an era of increasing globalisation and 
access to information through new technologies. While adolescents 
comprise about 25% of the global population, they constitute up to 
40% of the population in sub-Saharan Africa, creating what is also 
referred to as the ‘youth bulge’ in the population pyramid. This 
demographic shift in sub-Saharan Africa is also associated with 
poorer health outcomes in adolescents as a result of a convergence 
of communicable and non-communicable diseases. Notably, the 
gender gaps in infant and childhood survival are being reversed, with 
secondary sexual development resulting in increasing vulnerability of 
young women, which perpetuates vicious cycles of intergenerational 
poverty, low levels of schooling, and ill health that undermine social 
and economic transformation in these settings. 
Given the importance of this topic, the SAMJ has dedicated two 
special CME issues to it. In this first part, the focus is on sexual and 
reproductive health, including HIV and AIDS. The contribution by 
Baxter and Moodley[1] highlights the negative outcomes of teenage 
pregnancies and the impact on maternal mortality rates and indirect 
impact on infant mortality rates and overall increase in disease 
burden of HIV and tuberculosis. The article by Dellar et al.[2] links and 
contextualises HIV service provision with other sexual reproductive 
health needs of young women and provides specific guidance 
to clinicians on opportunities and specific action that clinicians 
can take in providing health services to adolescents. While there 
have been huge reductions in vertical transmission of HIV and a 
decline in AIDS-related deaths in infants with early antiretroviral 
(ARV) treatment initiation, these infants and children are now 
transitioning to adolescence. In addition to the usual challenges 
faced 
